Clinical Trials
Closed
Phase
Accrual
32%
Published
SWOG Clinical Trial Number
S1701
A Randomized Phase II trial of Carboplatin-Paclitaxel with or without Ramucirumab in Patients with Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
Status Notes
Permanent Closure - Effective 09/29/2022
Research Committee(s)
Lung Cancer
Activated
08-09-2018
Closed
10-15-2022
ClinicalTrials.gov Registry Number
03694002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1512
A Phase II Study of PD-1 Blockade with Pembrolizumab In Patients with Locally Advanced and Metastatic Desmoplastic Melanoma (DM)
Status Notes
This study will permanently close to accrual, effective 6/4/21.
Research Committee(s)
Melanoma
Activated
10-20-2016
Closed
06-04-2021
ClinicalTrials.gov Registry Number
NCT #02775851
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1416
Phase II Randomized Placebo-Controlled Trial of Cisplatin with or without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer (TNBC) and/or BRCA Mutation-Associated Breast Cancer, with or without Brain Metastases
Status Notes
S1416 is closed to accrual and treatment effective 12/31/2024.
Research Committee(s)
Breast Cancer
Activated
07-07-2016
Closed
06-15-2019
Closed
Phase
Accrual
29%
Published
SWOG Clinical Trial Number
S1403
A Randomized Phase II Trial of Afatinib Plus Cetuximab Versus Afatinib Alone In Treatment-Naïve Patients With Advanced, EGFR Mutation Positive Non-Small Lung Cancer (NSCLC)
Status Notes
This study permanently closed to accrual effective April 23, 2018.
Research Committee(s)
Lung Cancer
Activated
03-25-2015
Closed
04-23-2018
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1202
A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer
Status Notes
This protocol will be permanently closed to accrual effective 10/1/15.
Research Committee(s)
Symptom Management and Survivorship
Breast Cancer
Activated
05-15-2013
Closed
10-01-2015
ClinicalTrials.gov Registry Number
NCT01598298
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1216
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
03-01-2013
Closed
11-23-2025
ClinicalTrials.gov Registry Number
NCT01809691